BCAL DIAGNOSTICS LIMITED — Director's Dealing 2026

Mar 19, 2026

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity BCAL DIAGNOSTICS LIMITED ABN 51 142 051 223

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Jayne Shaw
Date of last notice	19 March 2026

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct & Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Entities controlled by the Director
Date of change	19-20 March 2026
No. of securities held prior to change	Nabelle Pty Ltd A/C> 22,986,662 ordinary shares Nabelle Pty Ltd 1,742,025 ordinary shares Nabelle Pty Ltd 6,097,481 ordinary shares OPSC Pty Ltd 2,651,779 ordinary shares Jayne Shaw Ordinary shares 2,022,638 Jayne Shaw 2,000,000 options exercise price $0.25 expiry date 8 October 2027.
Class	Ordinary shares
Number acquired	225,000
Number disposed	Nil

• See chapter 19 for defined terms.

11/3/2002

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$21,835
No. of securities held after change	Nabelle Pty Ltd A/C> 22,986,662 ordinary shares Nabelle Pty Ltd 1,742,025 ordinary shares Nabelle Pty Ltd 6,322,481 ordinary shares OPSC Pty Ltd 2,651,779 ordinary shares Jayne Shaw Ordinary shares 2,022,638 Jayne Shaw 2,000,000 options exercise price $0.25 expiry date 8 October 2027.
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	On Market Purchase

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
Interest after change

Part 3 –[+] Closed period

Part 3– +Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002